comparision of Dexmedetomidine and Thiopental with ?Dexmedetomidine and Ketamin on hemodynamic response ?and duration of seizure in patients candidated for ECT
Phase 2
Recruiting
- Conditions
- Electroconvulsive therapy.
- Registration Number
- IRCT20141209020258N81
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
no addiction
Exclusion Criteria
Seizures are less than 25 seconds or they may have arrhythmias or hemodynamic threats during the ECT
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of recovery. Timepoint: fisrt and end of recovery. Method of measurement: minute.;Duration of seizure after entering recovery. Timepoint: start and end of seizure. Method of measurement: minute.;Blood pressure. Timepoint: Before and after ECT and recovery. Method of measurement: Barometer.;Heart rate. Timepoint: Before and after ECT and recovery. Method of measurement: Beats in minutes.;Duration of seizure. Timepoint: Start and end of seizure. Method of measurement: Minute.
- Secondary Outcome Measures
Name Time Method